Diabetic nephropathy progresses through a series of stages with increasing severity, eventually culminating in end-stage renal failure (ESRF). Aggressive medical management during early stages can slow or prevent progression in many patients.
Parameters:
(1) glomerular filtrate rate (GFR)
(2) urine albumin excretion
(3) blood pressure
GFR (percent of normal) |
Urine Albumin |
Blood Pressure |
Stage |
---|---|---|---|
130 - 140% |
< 30 mg per day |
normal |
I |
90 - 140% |
< 30 mg per day |
normal |
II |
usually normal |
30 to 300 mg per day |
increases if left untreated |
III |
may be normal early, then declines |
> 300 mg per day |
hypertension in most |
IV |
low |
> 300 mg per day |
hypertension, often poorly controlled |
V |
where:
• Stage I nephropathy shows an increase in glomerular filtration.
• Normal urine albumin excretion is < 20 micrograms per minute or < 30 mg per day.
• Hyperfiltration in Stage II is a poor prognostic sign seen in patients with poor diabetic control.
Stage |
Renal Failure |
---|---|
I |
NA |
II |
NA |
III (incipient) |
incipient |
IV (overt) |
overt |
V (ESRF) |
symptomatic end-stage (ESRF) |
Signs and symptoms seen in Stage V:
(1) lethargy
(2) progressive weakness
(3) anorexia
(4) nausea and vomiting
(5) fluid retention
(6) diarrhea
(7) pruritis
Laboratory findings in Stage V:
(1) anemia
(2) electrolyte abnormalities
Purpose: To evaluate a patient with diabetes for diabetic nephropathy.
Specialty: Nephrology, Clinical Laboratory, Endocrinology
Objective: severity, prognosis, stage
ICD-10: E10.2, E11.2, E12.2, E13.2, E14.2,